Femasys (FEMY) Total Liabilities (2020 - 2026)
Femasys' (FEMY) quarterly Total Liabilities came in at $9.2 million in Q1 2026, down 18.4% YoY from $11.3 million in Q1 2025, and down 38.03% on a QoQ basis from $14.9 million in Q4 2025.
Femasys (FEMY) Total Liabilities (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Total Liabilities data on file, last reported at $9.2 million in Q1 2026.
- Quarterly Total Liabilities fell 18.4% year-over-year to $9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (down 18.4% YoY) and the FY2025 annual result came in at $14.9 million, up 46.49% from the prior year.
- Total Liabilities retreated to $9.2 million in Q1 2026, from $14.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $14.9 million in Q4 2025 to a low of $1.4 million in Q2 2023.
- A 5-year average of $7.2 million and a median of $9.0 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities slumped 34.14% — and 2024, when it surged 527.78%.
- Tracing FEMY's Total Liabilities over 5 years: stood at $1.7 million in 2022, then soared by 468.84% to $9.4 million in 2023, then grew by 7.84% to $10.1 million in 2024, then soared by 46.49% to $14.9 million in 2025, then slumped by 38.03% to $9.2 million in 2026.
- The last three Total Liabilities figures came in at $9.2 million (Q1 2026), $14.9 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.89 Bn | 127.67 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 51.87 Bn | 51.01 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.51 Bn | 34.16 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.52 Bn | 32.06 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 28.31 Bn | 25.63 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.26 Bn | 14.86 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Femasys | 9.90 Mn | 8.46 Mn | 189,391.00 | 8.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.21 Mn |
| Dec 31, 2025 | 14.85 Mn |
| Sep 30, 2025 | 11.73 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Mar 31, 2025 | 11.28 Mn |
| Dec 31, 2024 | 10.14 Mn |
| Sep 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 9.03 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Sep 30, 2023 | 4.41 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 2.18 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | 2.24 Mn |
| Sep 30, 2021 | 2.51 Mn |
| Jun 30, 2021 | 3.11 Mn |